Side-by-side comparison of AI visibility scores, market position, and capabilities
Science-led synbiotic brand; $56M revenue, profitable, top-5 Amazon probiotic ranking, and expanding into AI-driven microbiome research.
Seed Health is a Los Angeles-based microbial sciences company founded in 2018 by Ara Katz and Raja Dhir. The company is best known for its DS-01 Daily Synbiotic, a two-in-one probiotic and prebiotic capsule developed in partnership with academic researchers. Seed has raised approximately $44 million in total funding, with a Series A led by The Craftory, and has achieved profitability.\n\nThe company reported approximately $56 million in revenue with 500%+ growth over three years, ranking among Amazon's top-five probiotic supplements and selling in Target stores nationwide. Seed differentiates itself by emphasizing clinical research transparency — each strain is backed by published studies, and the brand has become a go-to reference among health-conscious consumers and clinicians.\n\nBeyond consumer products, Seed operates a scientific research arm called SeedLabs that conducts microbiome research in areas including planetary health and pediatric immunity. In 2024, the company announced an AI-powered initiative to accelerate strain discovery. This dual consumer-science identity gives Seed unusual credibility in a supplement category often criticized for weak evidence.
Personalized vitamin subscription brand acquired by Bayer for $225M in 2020; continues as digital-native supplement label under Bayer Consumer Health.
Care/of is a New York-based personalized vitamin and supplement brand founded in 2016 by Craig Elbert and Akash Shah. The company popularized algorithm-driven supplement personalization, asking consumers a series of lifestyle and health questions to recommend a custom daily vitamin pack delivered by subscription. Care/of was acquired by Bayer in November 2020 at a $225 million valuation, giving Bayer a majority ownership stake in the direct-to-consumer brand.\n\nUnder Bayer's Consumer Health division, Care/of has continued to operate with its original DTC model and brand identity while leveraging Bayer's supply chain, clinical validation resources, and marketing infrastructure. The brand extended its product line to include protein powders, collagen supplements, and wellness shots, maintaining its personalization-first positioning in a crowded supplement market.\n\nCare/of targets millennial consumers who value personalized wellness plans and want evidence-cited ingredient explanations. The brand's website provides research citations for every recommended ingredient, a transparency approach that built early credibility and loyalty. As part of Bayer, Care/of benefits from credentialing by association with a global pharmaceutical brand while retaining its digital-native identity.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.